Subscribe
dacian-g-shutterstock-com
Dacian G / Shutterstock.com
3 September 2015Americas

Bass suffers another IPR setback

Hedge fund manager Kyle Bass’s Coalition for Affordable Drugs has suffered another setback in its bid to knock out allegedly spurious patents after the US Patent and Trademark Office (USPTO) declined to institute an inter partes review (IPR) of a patent owned by Biogen.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Bass targets the University of Pennsylvania in IPR petitions
1 September 2015   Hedge fund manager Kyle Bass’s group the Coalition for Affordable Drugs has targeted two patents owned by the University of Pennsylvania in the latest petition for an inter partes review.
Americas
Bass set for first IPR trial as Shire petition proceeds
9 October 2015   Hedge fund manger Kyle Bass has secured his first inter partes review trial after the Patent Trial and Appeal Board instituted a challenge against a patent owned by biopharmaceutical company Shire.
Americas
PTAB deals Bass another blow
21 October 2015   The Patent Trial and Appeal Board has rejected another inter partes review petition filed by hedge fund manager Kyle Bass’s organisation the Coalition for Affordable Drugs.


Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024
Americas
Amarin wins appeal to advance ‘skinny label’ suit over Hikma generic
27 June 2024
Biotechnology
Guardant Health files suit against Tempus AI
13 June 2024
Big Pharma
Roche fires lawsuit at Sinocare unit over blood glucose test strip patents
6 June 2024

More on this story

Americas
Bass targets the University of Pennsylvania in IPR petitions
1 September 2015   Hedge fund manager Kyle Bass’s group the Coalition for Affordable Drugs has targeted two patents owned by the University of Pennsylvania in the latest petition for an inter partes review.
Americas
Bass set for first IPR trial as Shire petition proceeds
9 October 2015   Hedge fund manger Kyle Bass has secured his first inter partes review trial after the Patent Trial and Appeal Board instituted a challenge against a patent owned by biopharmaceutical company Shire.
Americas
PTAB deals Bass another blow
21 October 2015   The Patent Trial and Appeal Board has rejected another inter partes review petition filed by hedge fund manager Kyle Bass’s organisation the Coalition for Affordable Drugs.

More on this story

Americas
Bass targets the University of Pennsylvania in IPR petitions
1 September 2015   Hedge fund manager Kyle Bass’s group the Coalition for Affordable Drugs has targeted two patents owned by the University of Pennsylvania in the latest petition for an inter partes review.
Americas
Bass set for first IPR trial as Shire petition proceeds
9 October 2015   Hedge fund manger Kyle Bass has secured his first inter partes review trial after the Patent Trial and Appeal Board instituted a challenge against a patent owned by biopharmaceutical company Shire.
Americas
PTAB deals Bass another blow
21 October 2015   The Patent Trial and Appeal Board has rejected another inter partes review petition filed by hedge fund manager Kyle Bass’s organisation the Coalition for Affordable Drugs.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB
Lewis Roca promotes tech expert to managing partner
Panitch Schwarze brings in molecular biologist
US targets ‘product hopping’ with biologic litigation curbs
UPC confirms validity of Edwards Lifesciences heart valve tech patent
ITC concludes row over biotech lab equipment between US and German rivals
UKIPO launches ‘revolutionary’ patent filing and AI tool
USPTO clarifies AI's role in patent eligibility